Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Rises By 7.1%

Alpha Tau Medical Ltd. (NASDAQ:DRTS) was the target of a large growth in short interest in December. As of December 31st, there was short interest totalling 72,600 shares, a growth of 7.1% from the December 15th total of 67,800 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average daily trading volume, of 45,600 shares, the short-interest ratio is presently 1.6 days.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reissued a “buy” rating and set a $9.00 price objective on shares of Alpha Tau Medical in a report on Friday, November 22nd.

Alpha Tau Medical Stock Up 0.3 %

NASDAQ:DRTS traded up $0.01 during trading hours on Friday, hitting $3.91. The stock had a trading volume of 92,315 shares, compared to its average volume of 51,170. The company has a 50 day simple moving average of $2.99 and a two-hundred day simple moving average of $2.50. Alpha Tau Medical has a one year low of $1.75 and a one year high of $4.08.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.